Different types of allospecific CTL clones identified by their ability to recognize peptide loading-defective target cells
✍ Scribed by Fumie Aosai; Claes Öhlen; Hans-Gustaf Ljunggren; Petter Höglund; Lars Franksson; Hidde Ploegh; Alain Townsend; Kias Kärre; Hans J. Stauss
- Publisher
- John Wiley and Sons
- Year
- 1991
- Tongue
- English
- Weight
- 973 KB
- Volume
- 21
- Category
- Article
- ISSN
- 0014-2980
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Allospecific immune responses against the MHC of another individual are remarkably strong, due to a high number of responding T cell clones. Although it has been demonstrated that some allospecific cytotoxic T lymphocytes (CTL) recognize peptides presented by allogeneic MHC class I molecules, it has remained unclear whether MHC molecules can be recognized directly. We used the H‐2~b~‐derived murine lymphoma mutant RMA‐S, which has a defect affecting peptide loading of class I molecules, to test whether recognition by allospecific CTL always requires the presence of peptides. Three types of anti‐H‐2K^b^ CTL clones can be distinguished by their ability to lyse RMA‐S target cells. Type A CTL clones efficiently lyse these target cells, the lysis by type B CTL clones is inefficient, and type C clones fail to lyse RMA‐S. Up‐regulation of the levels of H‐2K^b^ density improved lysis by type B clones, but did not lead to lysis by type C clones. Some type A and B CTL clones apparently can recognize class I molecules devoid of peptides, while others are likely to recognize peptides which are not affected by the presentation defect of RMA‐S. We suggest that type C clones are specific for peptides which are not presented by the mutant cells. The results show that the majority of alloreactive CTL recognize peptide/MHC complexes, while some CTL behave as if they can recognize class I molecules in the absence of MHC‐bound peptides.